Thrombopoietin Receptor Agonist [EPC]

12811 reported adverse events

Drugs of this class: ROMIPLOSTIM

These side effects are most commonly reported by patients taking drugs of the Thrombopoietin Receptor Agonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 1573
1 PLATELET COUNT DECREASED 1562
2 OFF LABEL USE 936
3 THERAPEUTIC RESPONSE DECREASED 934
4 PLATELET COUNT ABNORMAL 893
5 DEATH 878
6 THROMBOCYTOPENIA 833
7 HEADACHE 539
8 FATIGUE 416
9 ARTHRALGIA 334
See all common reactions for Thrombopoietin Receptor Agonist [EPC]

Drugs of the Thrombopoietin Receptor Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE MARROW RETICULIN FIBROSIS 117 0.4500
1 BIOPSY BONE MARROW ABNORMAL 90 0.2108
2 PLATELET COUNT ABNORMAL 893 0.1885
3 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 77 0.1869
4 SPLENECTOMY 130 0.1297
5 THROMBOCYTOSIS 281 0.0977
6 EVANS SYNDROME 28 0.0878
7 MYELOFIBROSIS 135 0.0551
8 IDIOPATHIC THROMBOCYTOPENIC PURPURA 85 0.0537
9 LYMPHADENITIS 79 0.0407
See all enriched reactions for Thrombopoietin Receptor Agonist [EPC]